Martin Shkreli, the boyish drug company entrepreneur who rocketed to infamy by jacking up the price of a life-saving pill from $13.50 to $750, was arrested by federal agents at his Manhattan apartment early the morning of Dec. 17 and charged with securities fraud (United States v. Shkreli, E.D.N.Y., 15-cr-637, indictment unsealed 12/17/15). He also was charged civilly by the Securities and Exchange Commission based on related alleged misconduct (SEC v. Shkreli, E.D.N.Y., 12/17/15.
Shkreli ignited a firestorm over drug prices in September and became a symbol of defiant greed. The federal case against him ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.